AUPH - Aurinia Pharma EPS and revenue in-line March, 19 2019 04:03 PM Aurinia Pharmaceuticals Inc Aurinia Pharma (NASDAQ:AUPH): Q4 GAAP EPS of -$0.17 in-line.Revenue of $0.03M in-line (flat Y/Y).Press ReleaseMore news on: Aurinia Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news,